Support for ground-breaking brain tumour research
INTEGRA Biosciences is supporting vital translational research into diffuse intrinsic ponsglioma (DIPG) – a rare childhood brain tumour.
Dr Alexander Beck’s DIPG Fighter research group at the Ludwig Maximilian University of Munich (LMU) focuses on finding new therapies for DIPG, which usually affects children between five and nine years of age, with no significant long-term survival beyond five years.
The group routinely uses a range of INTEGRA products – including the ASSIST PLUS pipetting robot, VOYAGER adjustable tip spacing pipettes, EVOLVE manual pipettes and PIPETBOY acu 2 pipette controllers – and INTEGRA is delighted to be supporting this valuable work with this year’s festive donation, helping the rapid translation of research findings to the clinic.
Other News
Featured Supplier
The Gold Standard Diagnostics Group, including Gold Standard Diagnostics Inc., Novatec Immundiagnostica GmbH, and Virotech Diagnostics GmbH, is a group of specialized diagnostic technologies companies known as well-established providers of comprehensive solutions in infectious disease testing, immunology and automation.
Through our passion to...
Upcoming Events
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
